A federal vaccine panel recently reshaped by US health secretary Robert F. Kennedy Jr., has voted to discourage the use of ...

Health Secretary RFK Jr. has replaced the entire federal vaccine advisory board with COVID-19 vaccine critics. This dramatic policy shift could force families to pay hundreds of dollars out-of-pocket ...

It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

When the government pulls a public health ad campaign, it usually raises more questions than it answers. And when that ...

Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

The S&P 500 climbed 0.3% to 6,188.95, while the Nasdaq Composite added 0.3% at 20,328.90. The Dow Jones Industrial Average ...

WASHINGTON (dpa-AFX) - Biotechnology company Moderna, Inc. (MRNA) announced Monday positive results from a Phase 3 efficacy study evaluating the relative vaccine efficacy (rVE) against influenza ...